Delivery Order SPE2DB24D1201-SPE2DB24FJBHS

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,069.01. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of April 5, 2023. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of SHINGRIX vaccine vial kits to the Defense Logistics Agency (DLA). The $1,033.12 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 17, 2024 and was awarded on October 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $4,556.72, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of March 6, 2025. The contract is not designated as a set-aside award. In addition to this specific contract,...
This federal contract award is for the delivery of SHINGRIX VIAL KITS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,554.45. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA). The $1,987.36 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award represents a delivery order under a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $8,175.77. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 11, 2024. The contract is not associated with a set-aside designation, indicating...
This federal contract award is for the supply of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a defense agency. The $5,140.10 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 4, 2024. The contract has an ultimate completion date of December 5, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,139.18, is a firm fixed-price delivery order with a completion date of February 27, 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA). The contract, valued at $4,750.75, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 17, 2022. The contract is a Firm Fixed Price Delivery Order with a completion date of May 18, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB24FJBHS
    Delivery Order

This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for a fixed-price delivery order with a ceiling value of $8,521.64. The contract has an ultimate completion date of September 9, 2024.

AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, which serve as primary vehicles for providing a wide range of pharmaceutical and medical supplies to support military treatment programs, veterans' healthcare, and other government healthcare needs. This specific delivery order is likely part of a larger IDC between AmerisourceBergen and the DLA, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities.

The contract does not have a set-aside designation, indicating it was awarded through full and open competition. As a major supplier of essential medical products to the federal government, AmerisourceBergen's federal contracting activities play a critical role in supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries across various locations and healthcare settings.

Generated 12/6/24, 9:13 AM